Tu1263 Factors Associated With Hospital Readmissions in Patients With Inflammatory Bowel Disease (IBD)

Błoński, Wojciech; Synnestvedt, Marie; Tierney, Ann; Marchioni, Renée; Buchner, Anna M.; Lichtenstein, Gary R.

doi:10.1016/s0016-5085(12)63057-1

Cited by 1 publication

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…We identified 852 unique studies using our search strategy and reviewed 94 studies in detail and ultimately included 17 studies (6324 patients) in the quantitative analysis. [13][14][15][16][17][18][19][20][21][22][23][24][25][26][27][28][29] The study selection flowsheet is included in Figure 1. Of these 17 studies, 7 studies were fulllength articles and 10 were abstracts.…”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Rate of Risk Factors for and Interventions to Reduce Hospital Readmission in Patients With Inflammatory Bowel Diseases

Nguyen

Koola

Dulai

et al. 2020

Clinical Gastroenterology and Hepatology

View full text Add to dashboard Cite

BACKGROUND & AIMS: We investigated 30-and 90-day rates and causes of, risk factors for, and interventions to reduce hospital readmission in patients who received medical treatment for inflammatory bowel diseases (IBD). METHODS: We performed a systematic search of publications through July 1, 2018 for studies of rates of hospital readmission and associated causes and risk factors in patients who received medical treatments for IBD. Our final analysis included 17 cohort studies (6324 patients) of hospitalized adults with IBD who had received medical treatment, along with reported readmission rates with detailed chart review. We performed random effects meta-analysis to estimate 30-and 90day rates of readmission and identified causes and risk factors associated with readmission. We also performed qualitative analyses of studies that focused on interventions to reduce readmission. RESULTS: Overall, the 30-day rate of readmission was 18.1% (95% CI, 14.4-22.4) and the 90-day rate was 26.0% (95% CI, 22.7-29.6). On meta-regression, studies with higher proportions of patients with ulcerative colitis than Crohn's disease reported higher risks for readmission. Most common reasons for readmission were IBD flare, infection, or complications from unplanned surgeries during hospitalizations. Consistent risk factors for 30-day readmission were admission for pain control (odds ratio [OR], 2.27; 95% CI, 1.69-3.03), need for total parenteral nutrition on discharge (OR, 2.13; 95% CI, 1.36-3.35), and prior or unplanned surgery during admission (OR, 3.11; 95% CI, 2.27-4.25). Only 1 study focused on interventions (specialized inpatient IBD service) to reduce risk of readmission. CONCLUSIONS: Overall 30-and 90-day rates of readmission for patients who received medical treatment for IBD are 18.1% and 26.0%, respectively. IBD flares and infections are common reasons for readmission, and inadequate pain control and need for parenteral nutrition were common risk factors. Interventional studies to reduce risk of readmission are needed.

show abstract

Section: Resultsmentioning

confidence: 99%

“…Of these 17 studies, 7 studies were fulllength articles and 10 were abstracts. Sixteen studies were conducted in the United States [13][14][15][17][18][19][20][21][22][23][24][25][26][27][28][29] and all 13-16,18-26,28,29 but 2 studies were conducted at single centers. 17,27 Table 1 shows the study-level characteristics of included studies.…”

Section: Resultsmentioning

confidence: 99%